Jin S, Zhang L, Wang L
Many people use this peptide to assist with diabetic conditions and aid in weight loss
Retrieved from Yu, C., Wang, T., Gao, Y., et al
Gene-expression regulated by epigenetic modifications, such as alter DNA accessibility and chromatin structure, histone modification, and DNA methylation 1,2
Individual ingredients have documented metabolic roles, but the combined injectable formulation lacks rigorous clinical trial evidence for dramatic body composition changes
Semaglutide/L-Carnitine is used as a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).L- Carnitine is used as a fat shredder